Akebia Therapeutics (AKBA) Stock Highlights

0.94 | -6.93%

2024-06-21 04:38:59

Akebia Therapeutics Inc is a biopharmaceutical company. It focuses on the development and commercialization of novel therapeutics to patients with kidney disease through hypoxia-inducible factor (HIF) biology. Its lead product candidate is Vadadustat, an oral therapy, which is used for the treatment of anemia related to chronic kidney disease in non-dialysis and dialysis patients. The company is also developing a HIF-based portfolio of product for the treatment of anemia. Geographically, all the business activity is functioned through the region of United States.

Statistics

Range Today

0.94 1.01

Volume Today 4.44M

Range 1 Year

0.78 2.48

Volume 1 Year 650.07M

Range 3 Year

0.24 4.33

Volume 3 Year 2.83B

Range 10 Year

0.24 31

Volume 10 Year 5.13B

Highlights

Market Capitalization 234.75M (small)

Floating Shares 203.8M

Current Price 0.94

Price To Earnings -5.09

Price To Revenue 1.5

Earnings Per Share -0.22

Payout Ratio 0%

Performance

Latest -6.93%

1 Month -17.54%

3 Months -49.73%

6 Months -21.67%

1 Year -16.07%

3 Years -74.52%

5 Years -79.3%

10 Years -96.62%

Benchmarks

Market Capitalization

198 / 368

Gross Profits

41 / 278

Total Revenue

60 / 300

Total Rank

10 / 368

Free Cashflow

30 / 352

Performance 5 years

229 / 368

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.